NAD+ and sirtuins in aging and disease

✍ Scribed by Imai, Shin-ichiro; Guarente, Leonard

• Book ID: 122950748
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 617 KB
• Volume: 24
• Category: Article
• ISSN: 0962-8924
• DOI: 10.1016/j.tcb.2014.04.002

✦ Synopsis

Nicotinamide adenine dinucleotide (NAD+) is a classical coenzyme mediating many redox reactions. NAD+ also plays an important role in the regulation of NAD+-consuming enzymes, including sirtuins, poly-ADP-ribose polymerases (PARPs), and CD38/157 ectoenzymes. NAD+ biosynthesis, particularly mediated by nicotinamide phosphoribosyltransferase (NAMPT), and SIRT1 function together to regulate metabolism and circadian rhythm. NAD+ levels decline during the aging process and may be an Achilles’ heel, causing defects in nuclear and mitochondrial functions and resulting in many age-associated pathologies. Restoring NAD+ by supplementing NAD+ intermediates can dramatically ameliorate these age-associated functional defects, counteracting many diseases of aging, including neurodegenerative diseases. Thus, the combination of sirtuin activation and NAD+ intermediate supplementation may be an effective antiaging intervention, providing hope to aging societies worldwide.